Allergy, Immunology, and ENT

Latest News

Anaphylm (Photo courtesy of Aquestive Therapeutics.)
Anaphylm sublingual film demonstrates positive results in pediatric patients with severe allergic reactions

April 1st 2025

Aquestive Therapeutics reports positive pediatric study results for Anaphylm, supporting its FDA submission for treating severe allergic reactions.

FDA news in pedatrics: March 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA news in pedatrics: March 2025

April 1st 2025

Image Credit: © Татьяна Креминская - stock.adobe.com.
Omalizumab outperforms oral immunotherapy in treating multi-food allergy

March 27th 2025

Jay Rubinstein, MD, PhD, explains DB-OTO gene therapy in children with profound hearing loss
Jay Rubinstein, MD, PhD, explains DB-OTO gene therapy in children with profound hearing loss

March 7th 2025

FDA approves neffy for anaphylaxis in children aged 4 years and olderLatest revision | Image Credit: © Calin - © Calin - stock.adobe.com.
FDA approves neffy 1 mg for anaphylaxis in children aged 4 years and older

March 6th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.